BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.94
+0.36 (1.87%)
Feb 17, 2026, 11:32 AM EST - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $832.34 million as of February 17, 2026. Its market cap has increased by 385.73% in one year.
Market Cap
832.34M
Enterprise Value
527.12M
1-Year Change
385.73%
Ranking
Category
Stock Price
$19.94
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $832.34M, an increase of 35.34%. That is a compound annual growth rate of 24.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 817.10M | 72.25% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 1.31B |
| Evotec SE | 1.30B |
| Cronos Group | 998.00M |
| Pacira BioSciences | 936.57M |
| Tilray Brands | 874.97M |
| Esperion Therapeutics | 807.53M |
| Ironwood Pharmaceuticals | 732.05M |
| Emergent BioSolutions | 568.79M |